Barclays
BPTH

Barclays’s Bio-Path Holdings Inc BPTH Stock Holding History

Barclays’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-105
Closed -$43K – 7368
2019
Q1 		$43K Buy
+105
New +$19.3K ﹤0.01% 5994
2017
Q3 		– Sell
-10
Closed -$16K – 7107
2017
Q2 		$16K Buy
+10
New +$21K ﹤0.01% 5894
2017
Q1 		– Hold
0
– – – 7049
2016
Q4 		– Hold
0
– – – 6395
2016
Q3 		– Hold
0
– – – 6473
2015
Q2 		– Sell
-1
Closed -$2K – 7261
2015
Q1 		$2K Hold
1
– – ﹤0.01% 6900
2014
Q4 		$8K Buy
+1
New +$10.3K ﹤0.01% 6838
2014
Q3 		– Hold
0
– – – 7432
2014
Q2 		– Hold
0
– – – 7132

Other funds holding BPTH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Barclays's BPTH Position: Q2 2019 in Review

Barclays sold out of Bio-Path Holdings Inc (BPTH) in Q2 2019, closing a stake of 105 shares — an estimated $43K sold.

Barclays first reported a position in BPTH in Q4 2014 and held it in 4 quarters. The position peaked at $43K in Q1 2019. 17 funds tracked by Wall St. Rank hold BPTH as of Q2 2019.

  • Barclays reported no remaining Bio-Path Holdings Inc position as of Q2 2019 after selling out during the quarter.
  • Barclays sold 105 Bio-Path Holdings Inc shares in Q2 2019, an estimated $43K.
  • Barclays first reported a position in Bio-Path Holdings Inc in Q4 2014 and held it in 4 quarters.
  • Barclays's Bio-Path Holdings Inc position peaked at $43K in Q1 2019.
  • 17 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2019.

Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.